Loading clinical trials...

Continuous Versus Intermittent cARdiac Electrical moNitorinG | Clinical Trials | Clareo Health

RECRUITINGNA

Continuous Versus Intermittent cARdiac Electrical moNitorinG

NCT04336644•Washington University School of Medicine

Summary

The purpose of this study is to validate the continuous patch monitoring system to evaluate cardiac arrhythmias in patients receiving drugs that can cause cardiac complications and compare the continuous patch system with standard electrocardiograms (ECGs).

Eligibility

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•Diagnosis of acute promyelocytic leukemia (APL) and being initiated on standard of care arsenic trioxide OR Diagnosis of solid tumor and being initiated on standard of care capecitabine (alone or as part of combination treatment) OR Diagnosis of solid tumor and being initiated on standard of care ribociclib (alone or as part of combination treatment)
•At least 18 years of age.
•No allergy to adhesive patches.
•Able to understand and willing to sign an IRB-approved written informed consent document.

Exclusion Criteria

•Younger than 18 years of age
•Allergy to adhesive patches

Locations (1)

Washington University School of Medicine

St Louis, Missouri, United States

Key Dates

Start Date

November 21, 2023

Primary Completion Date

December 31, 2026

Completion Date

December 31, 2026

Last Updated

December 30, 2025

Enrollment

ESTIMATED participants

Conditions

Torsades de Pointe Caused by DrugLong QT Syndrome

Interventions

BodyGuardian Mini Plus

DEVICE

Contacts

Joshua D Mitchell, M.D., FACC

CONTACT

314-494-3124 jdmitchell@wustl.edu

Kaitlin Moore

CONTACT

314-273-0830 kaitlin.m.moore@wustl.edu

Evaluation of Efficacy and Safety of THRV-1268 in Long QT Syndrome Type 2 (LQTS 2)

NCT07277582

Long QT Syndrome (LQTS) 2

View study

RECRUITING

Evaluation of Exercise Testing and Physical Activity in Children and Adolescents Living With Inherited Arrhythmias

NCT06661278

Long QT SyndromeCatecholaminergic Polymorphic Ventricular Tachycardia Type 1+1 more

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: December 30, 2025Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Continuous Versus Intermittent cARdiac Electrical moNitorinG

Inclusion Criteria

Exclusion Criteria

Evaluation of Efficacy and Safety of THRV-1268 in Long QT Syndrome Type 2 (LQTS 2)

Evaluation of Exercise Testing and Physical Activity in Children and Adolescents Living With Inherited Arrhythmias

Hearts in Rhythm Organization (HiRO)National Registry and Bio Bank

A Study to Evaluate Accuracy and Validity of the Chang Gung ECG Abnormality Detection Software

KCNQ1 Cascade Screening

Effect of Grapefruit on QT Interval in Healthy Volunteers and Patients With Congenital Long QT Syndrome